Gondia, India, Oct. 07, 2024 (GLOBE NEWSWIRE) -- In 2023, the Antibody Drug Conjugates market size was valued at USD 5,475.84 Million and is expected to reach USD 39,153.21 Million at the CAGR of 24.0 ...

A clinical trial of an experimental vaccine against Marburg virus has begun in Rwanda, where an outbreak has led to 49 cases ...

Otulfi was approved simultaneously in the European Union. In the US, it will launch in February 2025.

A formula, a lab full of beakers and pipettes, and a competent scientist is on her way to manufacturing a generic drug. By contrast, Herceptin is a monoclonal antibody, a large “biologic ...

Tulisokibart is a tumor necrosis factor–like cytokine 1A (TL1A) monoclonal ... severity. Antibodies to tulisokibart were measured with the use of a high-sensitivity, drug-tolerant assay.

Absci Corporation (NASDAQ:ABSI) is working on developing the use of its biological drug ABS-101 for the treatment of patients with inflammatory bowel disease [IBD]. This drug is already de-risked ...

Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite ...

nano-drugs, monoclonal antibody drugs, bispecific antibody drugs, ADCs and biological drugs in the immune field. About Alphamab Oncology Alphamab Oncology is a leading biopharmaceutical company ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

This fall and winter, Ontario, Quebec and Nunavut will offer the newer monoclonal antibody nirsevimab — approved by Health ...

Immunovant stock rises on mid-stage study data of batoclimab for Graves' Disease, showing superior efficacy compared to ...